XOMA Royalty (XOMA) Share-based Compensation (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Share-based Compensation came in at $2.3 million in Q1 2026, up 15.03% year-on-year from $2.0 million in Q1 2025, and down 41.74% quarter-over-quarter from $3.9 million in Q4 2025.

XOMA Royalty (XOMA) Share-based Compensation (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Share-based Compensation across 17 years of filings, most recently posting $2.3 million for Q1 2026.

  • Share-based Compensation for Q1 2026 came in at $2.3 million, up 15.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.1 million (down 14.55% YoY), and the FY2025 annual result was $9.3 million, down 10.08% from the prior year.
  • Share-based Compensation came in at $2.3 million for Q1 2026 at XOMA Royalty, down from $3.9 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $3.9 million in Q4 2025 to a low of $100000.0 in Q2 2025.
  • The 5-year median for Share-based Compensation is $2.2 million (2023), against an average of $1.9 million.
  • Across the five-year window, Share-based Compensation jumped 237.1% in 2023 and plunged 96.28% in 2025, its largest moves.
  • XOMA Royalty's Share-based Compensation stood at $988000.0 in 2022, then surged by 168.12% to $2.6 million in 2023, then declined by 17.86% to $2.2 million in 2024, then jumped by 79.92% to $3.9 million in 2025, then plunged by 41.74% to $2.3 million in 2026.
  • The last three Share-based Compensation figures came in at $2.3 million (Q1 2026), $3.9 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 305,000.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 166.40 Mn
9 Abivax 95.45 Bn 95.45 Bn - 26.47 Mn
10 XOMA Royalty 5.52 Mn -60.56 Mn - 2.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.28 Mn
Mar 31, 2026 2.28 Mn
Dec 31, 2025 3.92 Mn
Dec 31, 2025 3.92 Mn
Sep 30, 2025 1.77 Mn
Sep 30, 2025 1.77 Mn
Jun 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 1.98 Mn
Mar 31, 2025 1.98 Mn
Dec 31, 2024 2.18 Mn
Dec 31, 2024 2.18 Mn
Sep 30, 2024 2.59 Mn
Sep 30, 2024 2.59 Mn
Jun 30, 2024 2.69 Mn
Jun 30, 2024 2.69 Mn
Mar 31, 2024 2.86 Mn
Mar 31, 2024 2.86 Mn
Dec 31, 2023 2.65 Mn
Dec 31, 2023 2.65 Mn